Ad
related to: amgnsuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the Tech24 Deals Content Network
On Tuesday, Amgen Inc. (NASDAQ:AMGN) reported second-quarter sales of $8.39 billion, up 20% year over year and beating the consensus of $8.33 billion. Product sales grew 20%, driven by 26% volume ...
Tuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDAQ:AZN) Soliris (eculizumab) to treat certain rare ...
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [ 3][ 4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [ 5]
The biotech Amgen (NASDAQ: AMGN) isn't exactly known as a growth stock. Over the past few years, the company's organic revenue hasn't been increasing at a particularly impressive rate. The ...
May 3, 2024 at 5:07 PM. Amgen's ( AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday. CEO Bob Bradway shared a ...
AM General is an American heavy vehicle and contract automotive manufacturer based in South Bend, Indiana. It is best known for the civilian Hummer and the military Humvee that are assembled in Mishawaka, Indiana. [ 4] From 1974–1979 the company also manufactured transit buses, making more than 5,400 of them. [ 5]
Amgen narrowed its 2024 adjusted earnings estimate and now expects a profit of $19.10 to $20.10 per share, compared with its previous view of $19.00 to $20.20. Analysts have forecast 2024 earnings ...
The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue grower ...
Ad
related to: amgnsuperstockscreener.com has been visited by 10K+ users in the past month